SELLAS Life Sciences (SLS) Invested Capital (2019 - 2024)
Historic Invested Capital for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $15.9 million.
- SELLAS Life Sciences' Invested Capital rose 51526.0% to $15.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $15.9 million, marking a year-over-year increase of 51526.0%. This contributed to the annual value of -$8.0 million for FY2023, which is 26441.97% down from last year.
- Per SELLAS Life Sciences' latest filing, its Invested Capital stood at $15.9 million for Q3 2024, which was up 51526.0% from $2.9 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences' Invested Capital peaked at $33.4 million during Q2 2021, and registered a low of -$8.0 million during Q4 2023.
- Moreover, its 5-year median value for Invested Capital was $9.7 million (2024), whereas its average is $12.2 million.
- As far as peak fluctuations go, SELLAS Life Sciences' Invested Capital surged by 78329.37% in 2021, and later plummeted by 26441.97% in 2023.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Invested Capital stood at $28.0 million in 2020, then dropped by 27.23% to $20.3 million in 2021, then plummeted by 76.16% to $4.9 million in 2022, then tumbled by 264.42% to -$8.0 million in 2023, then skyrocketed by 299.25% to $15.9 million in 2024.
- Its last three reported values are $15.9 million in Q3 2024, $2.9 million for Q2 2024, and $9.7 million during Q1 2024.